Back to Authors

Allyse, Megan A

0000-0001-6136-9256

Mayo Clinic

Department of Obstetrics & Gynecology, Mayo Clinic, Rochester, MN, USA.

Citations 58

Prevalence of Second Victim Experiences in a Cohort of Healthcare Learners and the Impact on Their Well-Being
Torbenson, Vanessa E. , Riggan, Kirsten A. , Stonnington, Cynthia M. , Huang, Lily , Perlman, Adam , Vadeboncoeur, Tyler F. , Allyse, Megan , Finney, Robyn E. , Rivera‐Chiauzzi, Enid Y. , Abu Dabrh, Abd Moain , Perlman, Adam , Vadeboncoeur, Tyler F , Allyse, Megan A , Finney, Robyn E , Rivera-Chiauzzi, Enid Y , Riggan, Kirsten A , Dabrh, Abd Moain Abu

Journal of Medical Education and Curricular Development | July 3, 2025 | Volume: 12 | Issue: No issue available | Pages: No page available

10.1177/23821205251340434 Get It

Objectives This study identified the prevalence of second victim experience (SVE) in a multidisciplinary sample of healthcare learners and explored personal experiences of trauma and desired forms of support following traumatic patient care events or situations. Method We used the validated SVE Support Tool-Revised and the Physician Well-Being Index (PWBI) to query healthcare learners at a large academic health system across the institution's medical, graduate medical education, and health sciences schools. The survey was open to all healthcare learners from April 8th, 2022 to May 30th, 2022. Here, we report on an analysis of respondents’ fixed responses describing the prevalence and characteristics of SVE. Results Of 2298 potential respondents, 206 answered at least one question (9.0% response rate). Of the 206 respondents, 205 answered questions inquiring if they had been a part of a stressful or traumatic patient care event or situation and 54.1% (111/205) answered in the affirmative. Of this group, 49.5% (51/103) reported feeling like a second victim (SV). The average PWBI of the exposed group was significantly higher (worse well-being) than the nonexposed group (3.4 vs 2.6, P = .0009). The most common forms of desired support for those exposed to a traumatic event and felt like an SV was conversation with peers 95.3% (41/43), family 81.4% (35/43), and a supervisor or manager 67.4% (29/43). Conclusion Findings suggest that many healthcare learners experience SVE and would benefit from connection to desired support strategies. Strategies to mitigate the impact of SVE on professional self-efficacy should be considered by education administrators. We present strategies from the literature and our institution that may be replicated for early identification and support of learners with SVE.
The impact of body size, prior care quality, and weight gain on health care utilization during the COVID‐19 pandemic
Phelan, Sean M. , Barwise, Amelia , Akambase, Jay‐Sharee P., Johnson, Matthew G. , Huang, Lily , Allyse, Megan , Phelan, S M , Allyse, Megan A , Barwise, Amelia K , Philip, Samantha R.

Clinical Obesity | June 12, 2025 | Volume: 15 | Issue: 5 | Pages: No page available

10.1111/cob.70019 Get It

SummaryThe goal of this study was to ascertain the effect of patient body size on clinic‐ or patient‐delayed health care during the COVID‐19 pandemic and factors predicting delay. Primary survey data were collected in August 2021 from 3593 individuals living within the communities near Mayo Clinic facilities in Minnesota, Wisconsin, Arizona, and Florida. More people who identified with the higher‐weight BMI categories reported having their care appointments cancelled (62.3%) compared to those who identified with normative weight (38.0%) or underweight (47.7%; p < .001) and reported more frequently delaying their own care (67.9%) relative to those who identified with normative weight (47.0%) or underweight (62.3%; p < .001). Higher‐weight people were more likely than others to report delay was due to not knowing where to get care (UW: 5.6%, NW: 3.5%, HW: 7.0%, pchi‐square < .001), worrying about weight‐based judgement (UW: 2.1%, NW: 2.1%, HW: 4.5%, pchi‐square < .001), and fearing discrimination (UW: 2.9%, NW: 2.4%, HW: 5.5%, pchi‐square < .001). There was no difference across groups in delay due to fear of COVID‐19 exposure. Weight gain was associated with care delay in higher‐weight and normative weight groups. Having experienced more patient‐centred care pre‐COVID was associated with less care delay in the normative weight group, but more care delay in other groups. Higher‐weight people were more likely to have their care delayed by health care providers and to delay care themselves. Patient weight gain and concerns about discrimination and judgement about weight gain may have driven the delay of needed care during COVID‐19.
Psychological Safety in the Medical Care of Black Breast and Ovarian Cancer Patients and Families
Yap, Jane Q. , Cobran, Ewan K. , Halyard, Michele Y. , James, Sarah E. , Kelly, Marion, Phillips, Daphne, Allyse, Megan , Kelly, Marion K, Phillips, Daphne T, Allyse, Megan A , Yap, Jane Q , Riggan, Kirsten A. , Phillips, Daphne T.

Psycho-Oncology | March 23, 2025 | Volume: 34 | Issue: 3 | Pages: No page available

10.1002/pon.70127 Get It

ABSTRACTBackgroundPsychological safety is critical to early and continued engagement with healthcare providers, yet no studies have explored this concept in relationship to cancer care. Black/African American (“Black”) individuals experience disparities in breast and ovarian cancer beyond what can be explained biologically.AimsWe explored factors influencing psychological safety among Black breast and ovarian cancer patients and their family members.MethodsSocioeconomically diverse patients with a personal diagnosis or family history of breast and/or ovarian cancer were invited to complete a semi‐structured qualitative interview on their cancer and healthcare experiences between September 2020 and April 2021. Informed by principles of grounded theory, interview transcripts were qualitatively analyzed for thematic content related to psychological safety.ResultsBlack breast and ovarian cancer patients and their family members described personal and community experiences and structural components of the healthcare system that suggested they may receive differential cancer care due to their race, placing them on guard. This posture was mediated by several self‐identified factors that added to or detracted from their comfort, including provider racial and gender concordance in healthcare, personalized care, and effective communication. The priorities and perceptions of care in participants receiving care in safety net clinics were more focused on what was feasible given resource limitations rather than what was ideally desired.ConclusionsImplementation of strategies to promote psychological safety with Black cancer patients may foster improved patient experiences, as well as encourage early screening, patient engagement, and treatment continuation.
Building Better Medicine: Translational Justice and the Quest for Equity in US Healthcare
Allyse, Megan , Agam, Preya , Bombard, Yvonne , Feys, Roel , Horstmann, McKenna , Kokayi, Assata , Isasi, Rosario , Meagher, Karen M. , Michie, Marsha , Musunuru, Kiran , Ormond, Kelly E. , Yap, Jane Q. , Allyse, Megan A , Riggan, Kirsten A , Yap, Jane Q , Meagher, Karen M , Riggan, Kirsten A.

The American Journal of Bioethics | February 24, 2025 | Volume: 25 | Issue: 6 | Pages: 11-25

10.1080/15265161.2025.2457713 Get It

Prenatal Care of Parents Who Continued Pregnancies With Down Syndrome, 2003–2022
Artal, Jonathan M. , Randall, Lindsey D. , Rubeck, Sabina , Allyse, Megan , Michie, Marsha , Riggan, Kirsten A. , Meredith, Stephanie , Skotko, Brian G. , Randall, Lindsey , Allyse, Megan A , Skotko, Brian G , Riggan, Kirsten A

American Journal of Medical Genetics Part A | January 20, 2025 | Volume: 197 | Issue: 5 | Pages: No page available

10.1002/ajmg.a.63981 Get It

ABSTRACTParents of children with Down syndrome have historically reported poor experiences receiving a prenatal diagnosis. In a 2003 survey, mothers reported that their physicians pitied them, emphasized negative aspects of Down syndrome, and encouraged them to terminate the pregnancy. This study assesses whether parents' perceptions have since improved. Community‐based organizations that had distributed the original 2003 survey distributed a similar survey to parents who have had a child with Down syndrome since 2003. Compared to the 2003 survey, parents continued to report dissatisfaction with their prenatal medical care (N = 60). Though subgroups became likelier to view their testing experience positively, parents' experiences worsened on certain metrics. Most parents reported dissatisfaction when providers conveyed pity or attempted to influence their decision‐making about the pregnancy. Interventions to date have failed to improve parents' perceptions of their prenatal medical support, urging new strategies to improve parents' care.
Barriers to Perinatal Care among Immigrant and Migrant Women in Southeast Minnesota
Reckhow, Jensen , Riggan, Kirsten A. , Bruetzman, Emily, Orellana, Minerva , Low, Stephanie, Tobah, Yvonne Butler , Rivera‐Chiauzzi, Enid Y. , Allyse, Megan , Torbenson, Vanessa E. , Rivera-Chiauzzi, Enid Y , Allyse, Megan A , Orellana, Minerva A , Riggan, Kirsten A

Women's Health Reports | October 29, 2024 | Volume: 5 | Issue: 1 | Pages: 842-848

10.1089/whr.2024.0108 Get It

Grounded in Reality: Integrating Community Values and Priorities of End Users in Human Gene Editing
Riggan, Kirsten A. , Feys, Roel , Kokayi, Assata , Meagher, Karen M. , Michie, Marsha , Musunuru, Kiran , Ormond, Kelly E. , Schelhaas, Andrea J. , Yap, Jane Q. , Isasi, Rosario , Allyse, Megan , Allyse, Megan A , Meagher, Karen M , Riggan, Kirsten A , Yap, Jane Q

The American Journal of Bioethics | August 19, 2024 | Volume: 24 | Issue: 8 | Pages: 43-45

10.1080/15265161.2024.2361880 Get It

“Down Syndrome is Not a Curse”: parent Perspectives on the Medicalization of Down Syndrome
Riggan, Kirsten A. , Michie, Marsha , Allyse, Megan , Allyse, Megan A , Riggan, Kirsten A

AJOB Empirical Bioethics | August 7, 2024 | Volume: 16 | Issue: 1 | Pages: 10-21

10.1080/23294515.2024.2388533 Get It

Parents of children with Down syndrome reflect on their postnatal diagnoses, 2003–2022
Artal, Jonathan M. , Randall, Lindsey, Rubeck, Sabina , Allyse, Megan , Meredith, Stephanie , Skotko, Brian G. , Randall, Lindsey D. , Skotko, Brian G , Allyse, Megan A , Randall, Lindsey , Michie, Marsha , Riggan, Kirsten A.

American Journal of Medical Genetics Part A | April 15, 2024 | Volume: 194 | Issue: 8 | Pages: No page available

10.1002/ajmg.a.63619 Get It

Abstract A 2003 survey revealed the scope of mothers' dissatisfaction with their postnatal support following a diagnosis of Down syndrome (DS). Substantial proportions of mothers reported that providers conveyed diagnoses with pity, emphasized negative aspects of DS, and neglected to provide adequate materials explaining DS. This study follows up on the 2003 survey by assessing whether parents' experiences have improved. Four DS nonprofit organizations, which participated in the original study, distributed a mixed‐methods survey to families who have had children with DS between 2003 and 2022. Quantitative analysis assessed correlations among responses and differences between the 2003 and 2022 survey groups. Open‐ended responses were qualitatively analyzed. Compared to the 2003 findings, parents' perceptions of their postnatal care have not improved ( N = 89). Parents are increasingly likely to report that their providers pitied them, omitted positive aspects of DS, and provided insufficient materials describing DS. Substantial proportions of parents reported fear (77%) and anxiety (79%), only 24% described receiving adequate explanatory materials, and parents were 45% likelier to report that physicians discussed negative aspects of DS than positive aspects. Qualitatively, substantial numbers of parents recounted insensitive conduct by providers. These results suggest that despite interventions, parents' experiences of postnatal diagnoses of DS have not improved over time. Certain provider behaviors—such as describing positive aspects of DS and providing comprehensive explanatory materials—can reduce fear and anxiety, pointing to directions for reform.
Patient experiences with prenatal cell‐free DNA screening in a safety net setting
Riggan, Kirsten A. , Barwise, Amelia , Yap, Jane Q. , Condon, Niamh, Allyse, Megan , Allyse, Megan A , Barwise, Amelia K , Riggan, Kirsten A , Yap, Jane Q

Prenatal Diagnosis | March 1, 2024 | Volume: 44 | Issue: 4 | Pages: 409-417

10.1002/pd.6541 Get It

AbstractObjectivesThirty‐five states, including Florida, now cover cell‐free DNA (cfDNA) screening of fetuses for all pregnant patients enrolled in state public insurance programs. We interviewed Black and Hispanic obstetric patients at a safety net clinic in Florida shortly after the state rolled out cfDNA as a first‐tier screening method for publicly insured patients.MethodsBlack and Hispanic patients receiving prenatal care from a prenatal or maternal fetal medicine clinic at a federally qualified health center in Jacksonville, FL were invited to participate in a qualitative interview in English or Spanish to explore experiences and perceptions of prenatal cfDNA screening. Participants were recruited following their first prenatal visit when cfDNA is typically introduced. Interview transcripts were qualitatively analyzed for iterative themes based on principles of grounded theory.ResultsOne hundred Black and Hispanic patients (n = 51 non‐Hispanic Black, n = 43 Hispanic, n = 3 Hispanic Black, n = 3 Not Reported/Other) completed an interview. Participants described minimal opportunity for pre‐screening counseling and limited health literacy about cfDNA or its uses. Some believed that cfDNA could positively impact pregnancy health. Many were unsure if they had received cfDNA even though they were aware of the information provided by it. Most participants expressed an interest in cfDNA as a means for early detection of fetal sex and as an additional indication of general fetal health.ConclusionsPatient experiences indicate limited informed consent and decision‐making for cfDNA, discordant with professional guidelines on pre‐screen counseling. Our findings suggest that there should be additional investment in implementing cfDNA in safety net settings to ensure that patients and providers receive the support necessary for effective patient counseling and follow‐on care for the ethical implementation of cfDNA.